소개 소식 자료실 Drug Screening Service STR,QC&서비스 특허&기탁 NGS & Drug Test Info. 생명연구자원 기탁등록보존 배양세포 클러스터 오가노이드분양 세포주분양

SNU-228

KCLB No. 00228
Name SNU-228
세포주 분양조건
서비스
수량
  • Information
  • STR data
  • Culture Morphology
  • NGS & Drug Info.
  • Culture Method
  • References
Origin kidney
Species human, asian - male, 51 years old, Mongoloid
Cellular morphology epithelial
Growth pattern monolayer
Histopathology renal cell carcinoma
Differentiation clear cell tye
Depositor Jae-Gahb Park, M.D.
D3S1358: 16
vWA: 14
FGA: 23
Amelogenin: X,Y
TH01: 6,9
TPOX: 8
CSF1PO: 11,12
D5S818: 10,12
D13S317: 11,13
D7S820: 10,12
Freezing media RPMI1640, 52.5%; FBS, 40%; DMSO, 7.5%
Original media RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%
KCLB media RPMI1640 with L-glutamine (300mg/L), 25mM HEPES and 25mM NaHCO3, 90%; heat inactivated fetal bovine serum (FBS), 10%
Subculture Remove medium, add fresh 0.25 % trypsin 0.02 % EDTA solution, stand culture flask at 37
Populaton doubling time 24 hours
Split ratio 1:4
Media change Remove two thirds of medium and add fresh medium (depending on cell density) every 2 to 3 days
Shin et al., Establishment and characterization of seven human renal cell carcinoma cell lines, BJU internaltional. 2000, 85:130-137
  • Shin KH, Ku JL, Kim WH, Lee SE, Lee C, Kim SW, Park JG.: Establishment and characterization of seven human renal cell carcinoma cell lines. BJU Int. 85: 1, 130-138. Jan
    ▶ Ref. KCLB Cell line No.'s - [ 00228, 00267, 00328, 00333, 00349, 00482, 01272 ]

Korean Cell Line Bank, Korean Cell Line Research Foundation,
101, Daehak-ro, Jongno-gu, Seoul, 03080, Korea
대표자 : 박재갑 | 개인정보보안책임자 : 신영경 | 사업자 등록번호 : 208-82-03887
통신판매업 신고 제2015-서울혜화-0125호 | Tel : 82-2-3668-7915
Fax : 82-2-742-0021 | Email : kclb@kclb.kr

KCLB (C) is a registered mark of Korean Cell Line Bank. All rights reserved. 1998~2015